There is a hypothesis that the relevant ratios of the survivin and splicing variants may regulate the ultimate apoptotic activities of cancer cells and determine their biological behaviours and responses to apoptosis-inducing treatment [37,40]. This evidence concerns the gene BIRC5 and cancer.